Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0001426812-15-000001
Filing Date
2015-02-12
Accepted
2015-02-12 14:04:30
Documents
1
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 5  
1 PRIMARY DOCUMENT primary_doc.xml 5 22303
  Complete submission text file 0001426812-15-000001.txt   24563
Mailing Address 123 SAGINAW DRIVE 123 SAGINAW DRIVE REDWOOD CITY CA 94063
Business Address 123 SAGINAW DRIVE REDWOOD CITY CA 94063 6503662626
HERON THERAPEUTICS, INC. /DE/ (Issuer) CIK: 0000818033 (see all company filings)

EIN.: 942875566 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address ONE MARKET PLAZA STEUART TOWER, SUITE 1400 SAN FRANCISCO CA 94105
Business Address ONE MARKET PLAZA STEUART TOWER, SUITE 1400 SAN FRANCISCO CA 94105 415-430-4200
SPCH, LLC (Reporting) CIK: 0001426812 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 5 | Act: 34 | File No.: 001-33221 | Film No.: 15604947

Mailing Address ONE MARKET PLAZA STEUART TOWER, SUITE 1400 SAN FRANCISCO CA 94105
Business Address
Midler Andrew R (Reporting) CIK: 0001558362 (see all company filings)

Type: 5 | Act: 34 | File No.: 001-33221 | Film No.: 15604946